R Rampling
- Genetics top 1%
- Glioma Diagnosis and Treatment 19
- Virus-based gene therapy research 8
- Genetics top 2%
- Glioma Diagnosis and Treatment 19
- Virus-based gene therapy research 8
- Neurology top 2%
- CNS Lymphoma Diagnosis and Treatment 6
- Oncology top 5%
-
- Lymphoma Diagnosis and Treatment 5
-
- Herpesvirus Infections and Treatments 6
-
- Radiopharmaceutical Chemistry and Applications 5
-
- Brain Metastases and Treatment 5
-
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Donald M. HadleyVakis PapanastassiouJ. HarlandRichard PettyJames A. R. NicollM. BrownG. CruickshankMatthew Fraser
- Journals
- British Journal of Cancer (7 papers)Clinical Oncology (4 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)
- Partner nations
- United KingdomItalyUnited States
In The Last Decade
R Rampling
47 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 105
- Genetics 704
- Genetics 1.0k
- Neurology 477
- Oncology 810
- Pathology and Forensic Medicine 359
Countries citing papers authored by R Rampling
This map shows the geographic impact of R Rampling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Rampling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Rampling more than expected).
Fields of papers citing papers by R Rampling
This network shows the impact of papers produced by R Rampling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Rampling. The network helps show where R Rampling may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R Rampling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 52 | |
| 2 | 2000 | 478 | |
| 3 | 2000 | 8 | |
| 4 | 2000 | 129 | |
| 5 | 2000 | 37 | |
| 6 | Medical Research Council (MRC) randomised trial of adjuvant chemotherapy in primary CNS lymphoma (PCL)- BR06. | 1998 | 1 |
| 7 | 1998 | 15 | |
| 8 | 1998 | 28 | |
| 9 | 1995 | 9 | |
| 10 | 1994 | 242 | |
| 11 | 1994 | 13 | |
| 12 | 1994 | 4 | |
| 13 | 1994 | 21 | |
| 14 | 1993 | 13 | |
| 15 | 1991 | 75 | |
| 16 | 1987 | 159 | |
| 17 | 1987 | 5 | |
| 18 | 1985 | 3 | |
| 19 | 1985 | 6 | |
| 20 | 1984 | 8 |
About R Rampling
R Rampling is a scholar working on Genetics, Biological Psychiatry, Neurology, Structural Biology and Pathology and Forensic Medicine, having authored 49 papers that have together received 2.7k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (19 papers), Virus-based gene therapy research (8 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Herpesvirus Infections and Treatments (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Brain Metastases and Treatment (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Genetics (704 citations), Genetics (1.0k citations), Neurology (477 citations), Oncology (810 citations) and Pathology and Forensic Medicine (359 citations). R Rampling has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Donald M. Hadley, Vakis Papanastassiou, J. Harland, Richard Petty, James A. R. Nicoll, M. Brown, G. Cruickshank, Matthew Fraser, Paul Workman and E. A. McKie. Their work appears in journals such as British Journal of Cancer, Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Journal of Neuro-Oncology and Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.